Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $1.80 USD
Change Today +0.05 / 2.86%
Volume 16.5K
As of 8:10 PM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Philip O. Livingston M.D.

Chief Science Officer and Director,MabVax Therapeutics Holdings, Inc.
AgeTotal Calculated CompensationThis person is connected to 35 board members in 3 different organizations across 4 different industries.

See Board Relationships


Prof. Philip O. Livingston, M.D. has been the Chief Science Officer of MabVax Therapeutics Holdings, Inc. since 2012. Prof. Livingston serves as the Head of the Laboratory of Tumor Vaccinology at MSKCC where he has treated cancer patients and conducted research for over 30 years. He is a Co-Founder of Adjuvance Technologies, Inc. He serves as Member of Scientific Advisory Board of Optimer Pharmaceuticals, Inc. He serves as a Member of the Cancer Scientific Advisory Board ...

Read Full Background

Corporate Headquarters*

11588 Sorrento Valley Road
San Diego, California 92121

United States

Phone: 858-259-9405
Fax: --

Board Members Memberships*

Chief Science Officer and Director


Unknown/Other Education
Princeton University
Unknown/Other Education
Harvard Medical School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MBVX:US $1.80 USD +0.05


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MABVAX THERAPEUTICS HOLDINGS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at